Ver publicación 

Mostrar el registro sencillo de la publicación

HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism

dc.contributor.authorRojas, Armando
dc.contributor.authorDelgado-López, Fernando
dc.contributor.authorPérez-Castro, Ramón
dc.contributor.authorGonzález-Bonet, Ileana
dc.contributor.authorRomero, Jacqueline
dc.contributor.authorRojas, Israel
dc.contributor.authorAraya, Paulina
dc.contributor.authorMorales-Mejías, Erik
dc.contributor.authorLlano, Jorge
dc.contributor.authorAñazco-Oyarzún, Carolina
dc.date.accessioned2017-10-03T17:54:25Z
dc.date.available2017-10-03T17:54:25Z
dc.date.issued2016
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/301
dc.description.abstractThe monocyte-macrophage lineage shows a high degree of diversity and plasticity. Once they infiltrate tissues,they may acquire two main functional phenotypes, being known as the classically activated type 1 macrophages (M1) and the alternative activated type 2 macrophages (M2). The M1 phenotype can be induced by bacterial products and interferon-γ and exerts a cytotoxic effect on cancer cells. Conversely, the alternatively activated M2 phenotype is induced by Il-4/IL13 and promotes tumor cell growth and vascularization. Although receptor for advanced glycation endproducts (RAGE) engagement in M1 macrophages has been reported by several groups to promote inflammation, nothing is known about the functionality of RAGE in M2 macrophages. In the current study, we demonstrate that RAGE is equally expressed in both macrophage phenotypes and that RAGE activation by high-mobility group protein box1 (HMGB1) promotes protumoral activities of M2 macrophages. MKN45 cells co-cultured with M2 macrophages treated with HMGB1 at different times displayed higher invasive abilities. Additionally, conditioned medium from HMGB1-treated M2 macrophages promotes angiogenesis in vitro. RAGE-targeting knockdown abrogates these activities. Overall, the present findings suggest that HMGB1 may contribute, by a RAGE-dependent mechanism, to the protumoral activities of the M2 phenotype.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceTumor Biology, 37(3), 3321-3329es_CL
dc.subjectReceptor for advanced glycation end productses_CL
dc.subjectHMGB1es_CL
dc.subjectMacrophage polarizationes_CL
dc.subjectTumor-associated macrophageses_CL
dc.titleHMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanismes_CL
dc.typeArticlees_CL
dc.ucm.facultadFacultad de Medicinaes_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.urisibib2.ucm.cl:2048/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edsgao&AN=edsgcl.450606247&lang=es&site=eds-live&scope=sitees_CL
dc.ucm.doidoi.org/10.1007/s13277-015-3940-yes_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile